CLOTRIMAZOLE EXTERNAL CREAM DIN 02443503
Health Canada record
| Active ingredient(s) | CLOTRIMAZOLE 1 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | G01AF02 CLOTRIMAZOLE |
| Original market date | |
| Current status date | 15-Jul-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOTRIMAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02150883 | CANESTEN 1 DAY INTERNAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 10 % | Marketed |
| 02150867 | CANESTEN 1% TOPICAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02150905 | CANESTEN 3 DAY INTERNAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 2 % | Marketed |
| 02150891 | CANESTEN 6 DAY INTERNAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02264102 | CANESTEN COMBI 1 DAY | BAYER INC | Vaginal Tablet; Cream; Kit | CLOTRIMAZOLE 500 MG; CLOTRIMAZOLE 1 % | Marketed |
| 02542064 | CANESTEN COMBI 1 DAY COMFORTAB + EXTRA STRENGTH EXTERNAL CREAM | BAYER INC | Cream; Kit; Vaginal Tablet | CLOTRIMAZOLE 500 MG; CLOTRIMAZOLE 2 % | Approved |
| 02230509 | CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS | BAYER INC | Cream; Kit | CLOTRIMAZOLE 1 %; CLOTRIMAZOLE 10 % | Marketed |
| 02547260 | CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM | BAYER INC | Cream; Kit; Vaginal Capsule | CLOTRIMAZOLE 500 MG; CLOTRIMAZOLE 2 % | Marketed |
| 02264099 | CANESTEN COMBI 3 DAY | BAYER INC | Kit; Cream; Vaginal Tablet | CLOTRIMAZOLE 200 MG; CLOTRIMAZOLE 1 % | Marketed |
| 02150859 | CANESTEN COMFORTAB 1 | BAYER INC | Vaginal Tablet | CLOTRIMAZOLE 500 MG | Marketed |
| 02150840 | CANESTEN COMFORTAB 3 | BAYER INC | Vaginal Tablet | CLOTRIMAZOLE 200 MG | Marketed |
| 02239432 | CANESTEN EXTERNAL ANTIFUNGAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02311720 | CANESTEN EXTERNAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02490927 | CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | BAYER INC | Cream | CLOTRIMAZOLE 2 % | Marketed |
| 02547252 | CANESTEN SOFT CAPSULE 1 | BAYER INC | Vaginal Capsule | CLOTRIMAZOLE 500 MG | Marketed |
| 00812382 | CLOTRIMADERM TOPICAL | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02236746 | CLOTRIMADERM TOPICAL SOLUTION 1% USP | TARO PHARMACEUTICALS INC | Liquid | CLOTRIMAZOLE 10 MG | Approved |
| 00812374 | CLOTRIMADERM VAGINAL 3 | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 2 % | Marketed |
| 00812366 | CLOTRIMADERM VAGINAL 6 | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02462397 | CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02503360 | CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 2 % | Marketed |
| 02229380 | CLOTRIMAZOLE TOPICAL | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02229379 | CLOTRIMAZOLE VAGINAL 3 | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 2 % | Marketed |
| 02229378 | CLOTRIMAZOLE VAGINAL 6 | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 1 % | Marketed |
| 02517760 | EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI | TARO PHARMACEUTICALS INC | Cream; Capsule | CLOTRIMAZOLE 2 %; FLUCONAZOLE 150 MG | Marketed |
| 02150948 | CANESTEN 1 VAGINAL TABLET COMBI-PAK | BAYER INC CONSUMER CARE | Suppository; Cream | CLOTRIMAZOLE 500 MG; CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02150875 | CANESTEN 1% TOPICAL SOLUTION | BAYER INC CONSUMER CARE | Solution | CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02150832 | CANESTEN 100MG VAGINAL INSERTS | BAYER INC CONSUMER CARE | Suppository | CLOTRIMAZOLE 100 MG | Cancelled Post Market |
| 02130262 | CANESTEN 2% VAGINAL CREAM | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Cream | CLOTRIMAZOLE 2 % | Cancelled Post Market |
| 02130211 | CANESTEN 200 MG VAGINAL INSERTS | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Suppository | CLOTRIMAZOLE 200 MG | Cancelled Post Market |
| 02150921 | CANESTEN 3 VAGINAL TABLET COMBI-PAK | BAYER INC CONSUMER CARE | Cream; Suppository | CLOTRIMAZOLE 200 MG; CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02130238 | CANESTEN COMBI-PAK 1 DAY THERAPY | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Cream; Suppository | CLOTRIMAZOLE 500 MG; CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02029502 | CANESTEN CRM 1% TOP | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Cream | CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02029499 | CANESTEN CRM 1% VAG | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Cream | CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02029510 | CANESTEN LIQ 1% | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Liquid | CLOTRIMAZOLE 1 % | Cancelled Post Market |
| 02029480 | CANESTEN VAGINAL INSERTS 100MG | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | Suppository | CLOTRIMAZOLE 100 MG | Cancelled Post Market |
| 02440938 | CLOTRIMADERM EXTERNAL CREAM | TARO PHARMACEUTICALS INC | Cream | CLOTRIMAZOLE 1 % | Cancelled Pre Market |
| 00516805 | MYCLO CRM 10MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Cream | CLOTRIMAZOLE 10 MG | Cancelled Post Market |
| 00516813 | MYCLO CRM 50MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Cream | CLOTRIMAZOLE 50 MG | Cancelled Post Market |
| 00516821 | MYCLO SOLUTION | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Liquid | CLOTRIMAZOLE 10 MG | Cancelled Post Market |
| 00516848 | MYCLO TAB 100MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Suppository | CLOTRIMAZOLE 100 MG | Cancelled Post Market |
| 02131676 | MYCLO-DERM CREAM 1% | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Cream | CLOTRIMAZOLE 10 MG | Cancelled Post Market |
| 02131668 | MYCLO-DERM SOLUTION 1% | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Solution | CLOTRIMAZOLE 10 MG | Cancelled Post Market |
| 02131641 | MYCLO-GYNE CREAM 1% | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Cream | CLOTRIMAZOLE 10 MG | Cancelled Post Market |
| 02131633 | MYCLO-GYNE INSERTS | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Suppository | CLOTRIMAZOLE 100 MG | Cancelled Post Market |
| 00874043 | NEO-ZOL CREAM 1% | PRESTIGE PHARMA INC | Cream | CLOTRIMAZOLE 1 % | Cancelled (Unreturned Annual) |
| 00874051 | NEO-ZOL VAGINAL CREAM 1% | PRESTIGE PHARMA INC | Cream | CLOTRIMAZOLE 1 % | Cancelled (Unreturned Annual) |
| 00874078 | NEO-ZOL VAGINAL CREAM 2% | PRESTIGE PHARMA INC | Cream | CLOTRIMAZOLE 2 % | Cancelled (Unreturned Annual) |
| 02230447 | SCHEINPHARM CLOTRIMAZOLE 1% | SCHEIN PHARMACEUTICAL CANADA INC. | Cream | CLOTRIMAZOLE 1 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34629 | 2024-12-31 | Supplement to an Abbreviated New Drug Submission (SANDS) | Update to Product Monograph (to align with CRP approved PM). Product Monograph reformatted to the Master Template. Update to package insert. |
| 17084 | 2015-07-15 | New Drug Submission (NDS) | ADDITIONAL PRODUCT NAME |
International API supply for CLOTRIMAZOLE
5 valid EDQM Certificates of Suitability from 5 holders. 5 active FDA Drug Master Files.
Request a quote for CLOTRIMAZOLE EXTERNAL CREAM